Global Cardiology Radiopharmaceuticals Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Cardiology Radiopharmaceuticals Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Cardiology Radiopharmaceuticals report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Cardiology Radiopharmaceuticals market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Therapeutic Use and Diagnostic Use are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Cardiology Radiopharmaceuticals industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Cardiology Radiopharmaceuticals key companies include GE Healthcare, Cardinal Health, Curium Pharma, Lantheus Medical Imaging, Inc., Eczacıbaşı Monrol Nuclear Products, Novartis International AG, Siemens, China Isotope & Radiation and Yantai Dongcheng Pharmaceutical, etc. GE Healthcare, Cardinal Health, Curium Pharma are top 3 players and held % share in total in 2022.
Cardiology Radiopharmaceuticals can be divided into Technetium-99, Fluorine-18, Gallium-67 and Others, etc. Technetium-99 is the mainstream product in the market, accounting for % share globally in 2022.
Cardiology Radiopharmaceuticals is widely used in various fields, such as Therapeutic Use and Diagnostic Use, etc. Therapeutic Use provides greatest supports to the Cardiology Radiopharmaceuticals industry development. In 2022, global % share of Cardiology Radiopharmaceuticals went into Therapeutic Use filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cardiology Radiopharmaceuticals market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
GE Healthcare
Cardinal Health
Curium Pharma
Lantheus Medical Imaging, Inc.
Eczacıbaşı Monrol Nuclear Products
Novartis International AG
Siemens
China Isotope & Radiation
Yantai Dongcheng Pharmaceutical
Jubilant Life Sciences
Bracco
Segment by Type
Technetium-99
Fluorine-18
Gallium-67
Others
Therapeutic Use
Diagnostic Use
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Cardiology Radiopharmaceuticals market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Cardiology Radiopharmaceuticals introduction, etc. Cardiology Radiopharmaceuticals Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Cardiology Radiopharmaceuticals market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
North America, Europe and Asia Pacific are the key regions for Cardiology Radiopharmaceuticals industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Cardiology Radiopharmaceuticals key companies include GE Healthcare, Cardinal Health, Curium Pharma, Lantheus Medical Imaging, Inc., Eczacıbaşı Monrol Nuclear Products, Novartis International AG, Siemens, China Isotope & Radiation and Yantai Dongcheng Pharmaceutical, etc. GE Healthcare, Cardinal Health, Curium Pharma are top 3 players and held % share in total in 2022.
Cardiology Radiopharmaceuticals can be divided into Technetium-99, Fluorine-18, Gallium-67 and Others, etc. Technetium-99 is the mainstream product in the market, accounting for % share globally in 2022.
Cardiology Radiopharmaceuticals is widely used in various fields, such as Therapeutic Use and Diagnostic Use, etc. Therapeutic Use provides greatest supports to the Cardiology Radiopharmaceuticals industry development. In 2022, global % share of Cardiology Radiopharmaceuticals went into Therapeutic Use filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cardiology Radiopharmaceuticals market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
GE Healthcare
Cardinal Health
Curium Pharma
Lantheus Medical Imaging, Inc.
Eczacıbaşı Monrol Nuclear Products
Novartis International AG
Siemens
China Isotope & Radiation
Yantai Dongcheng Pharmaceutical
Jubilant Life Sciences
Bracco
Segment by Type
Technetium-99
Fluorine-18
Gallium-67
Others
Segment by Application
Therapeutic Use
Diagnostic Use
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Cardiology Radiopharmaceuticals market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Cardiology Radiopharmaceuticals introduction, etc. Cardiology Radiopharmaceuticals Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Cardiology Radiopharmaceuticals market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices